Is Patient Advocacy A Forgotten Market Access Strategy?
Updated: Aug 5, 2019
The introduction to a five part video interview with Ellen Coleman, President and CEO of VOZ Advisors. Topics covered in the video series:
1. New R and D specific compliance guidelines 2. Biggest compliance challenges companies face 3. ROI measurement in early patient engagement 4. US and European patient advocacy; main differences